20:03 EST Cathie Wood’s ARK Investment buys 336K shares of Beam Therapeutics (BEAM) today
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- EQT, Cummins, Beam, Chubb, Amphenol: Insider Sales Unveiled
- Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
- Beam Therapeutics management to meet with Cantor
- Beam Therapeutics Advances BEAM-302 Study for AATD: Key Insights for Investors
- Video: This stock is dragging down the in vivo gene editing therapy space